Biotech China 2014

Stem Cells: Genentech

Total Score People Score Events Score
37 23 25
Date Event Presentation Speakers
May 6, 2014 Europe Drug Discovery Summit Europe Drug Discovery Summit Paul G. Polakis, Ingrid Wertz
March 2, 2014 Alzheimer’s Disease – From Fundamental Insights to Light at the End of the Translational Tunnel (Q8) Phenotypic and Genotypic Complexity of AD and PD (Joint) Registered attendees can view abstracts starting on 02/02/2014 Ryan J. Watts
February 2, 2014 Stem Cells and Cancer (J8) Targeting Developmental Pathways: Clinical Experience Frederic J. de Sauvage
Emerging Cancer Drug Targets in Development Pathways Weilan Ye
New Regulatory Pathways in Cancer Registered attendees can view abstracts starting on 01/02/2014 Vishva M. Dixit
February 2, 2014 Developmental Pathways and Cancer: Wnt, Notch and Hedgehog (J7) Stem Cells, Development and Cancer (Joint) Registered attendees can view abstracts starting on 01/02/2014 Frederic J. de Sauvage
Targeting Cancer Stem Cells: Trials and Translation Registered attendees can view abstracts starting on 01/02/2014 Vishva M. Dixit
Targeting Developmental Pathways: Clinical Experience Frederic J. de Sauvage
New Regulatory Pathways in Cancer Registered attendees can view abstracts starting on 01/02/2014 Vishva Dixit
Emerging Cancer Drug Targets in Development Pathways Registered attendees can view abstracts starting on 01/02/2014 Weilan Ye
September 15, 2013 ISSCR Regional Forum - Stem Cells in Translation Lineage Epigenetics Frederic J. de Sauvage
May 31, 2013 ASCO Annual Meeting 2013 The Many Faces of Hepatocellular Carcinoma: From Biology to Treatment Robert Kelley
April 6, 2013 AACR Annual Meetings Expanding the Druggable Genome Chairperson: Stephen W. Fesik, Vanderbilt University School of Medicine, Nashville, TN Domagoj Vucic
Mitotic Checkpoints Driving Cancer Therapeutic Strategies Chairperson: Peter K. Jackson, Genentech, Inc., South San Francisco, CA Peter K Jackson
March 19, 2013 Stem Cells for Drug Developers ESCs and iPSCs as Simple, Reproducible and Cost-Effective Tools for Toxicity Testing Hirdesh Uppal
February 25, 2013 4th Cancer Targets and Therapeutics Targeting Inhibitor of Apoptosis (IAP) Proteins for Anti-cancer Therapies Domagoj Vucic
Opposing Effects of Androgen Deprivation and Targeted Therapy on Prostate Cancer Prevention Shidong Jia
February 10, 2013 7thANNUAL DRUG DISCOVERY FOR NEURODEGENERATION CONFERENCE: An Intensive Course on Translating Research into Drugs Antibodies and Immunotherapy for Neurodegeneration Ryan J. Watts
February 3, 2013 New Frontiers in Neurodegenerative Disease Research (J8) Targeting Neurodegeneration by Boosting Antibody Uptake in Brain Ryan J. Watts
March 6, 2011 Stem Cells, Cancer and Metastasis (C4) Developmental Regulatory Pathways and Cancer Drug Discovery Frederic J. de Sauvage
May 20, 2010 Revival of Bispecific Antibodies: The Way Forward? bis-Fabs: A New Platform for Bispecific Molecules Justin M. Scheer
May 19, 2010 Towards Personalized Cancer Medicine Role of the Microenvironment in VEGF-Independent Angiogenesis Napoleone Ferrara
August 5, 2009 New Frontiers in Cancer Drug Development Cancer Stem Cells Chia Portera
Targeting the Hedgehog Pathway in Cancer Treatment Chia Portera
Bevacizumab in Patients with Previously Treated Glioblastoma Asha Das
January 5, 2009 High Content Analysis Chemical Reporters for Probing and Visualizing Lipoproteins and Lipids in Cells Rami Hannoush
Utility of Time-Resolved Binding Date for Fragment-Based Screening and HTS Hit Validation Using SPR Biosensors Anthony M Giannetti
Profiling p53 Networks by Cell-Based Multiplex Imaging Rami Hannoush
November 22, 2008 Collaborative Ependymoma Research Network (CERN) Clonal Analysis Reveals A Hierarchy Of Self-Renewing Tumor-Initiating Cell Types In Glioblastoma Heidi Phillips
May 30, 2008 ASCO Annual'08 Meeting professional development-- Contract Negotiations for Your First Job in Industry, Private Practice, or Academia Sean P. Bohen
March 30, 2008 Inflammation, Microenvironment and Cancer Innate Immunity and Cancer Vishva M. Dixit
March 25, 2008 CYTOKINE-BASED THERAPEUTICS Preclinical Studies of Anti-OX40L in TH2-Driven Diseases Sarah Hymowitz
Title to Be Determined Vishva M. Dixit
February 17, 2008 Wnt/beta-Catenin Signaling in Development and Disease Pharmacological Modulation of Wnt Signaling Paul G. Polakis
January 22, 2008 Ubiquitin and Cancer: From Molecular Targets and Mechanisms to the Clinic KEYNOTE ADDRESS Vishva M. Dixit
SESSION 2: ONCOGENIC SIGNALING II Vishva M. Dixit
January 15, 2008 Molecular, Cellular, Physiological, and Pathogenic Responses to Hypoxia Extracellular Matrix and Angiogenesis Weilan Ye
November 14, 2007 Advances in Breast Cancer Research Therapeutic Intervention in Wnt Signaling in Cancer Paul G. Polakis
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 7: Anti-Cancer/Tumors Drug Discovery & Development and Current Status of the Innovative Therapeutics (Part II) (09:00-12:00) Mark S. Dennis
Session 7: Tumor Targeting with an AB.Fab (09:00-09:20) Mark S. Dennis
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.